A histochemical study of iron and ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys

被引:0
|
作者
Goto, K
Mochizuki, H
Imai, H
Akiyama, H
Mizuno, Y
机构
来源
BASAL GANGLIA V | 1996年 / 47卷
关键词
D O I
暂无
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Iron is increased in the substantia nigra of patients with Parkinson's disease (PD). The mechanism of its accumulation, however, remains to be explored. In this study, we stereotactically injected MPTP into the unilateral putamen or caudate nucleus of six monkeys. The substantia nigra and the basal ganglia regions were stained for iron and ferritin by histochemical methods. We found a marked increase in the intensity of iron staining in the pars compacta of the substantia nigra. On the other hand, no significant difference was noted between the injected side and the non-injected side in ferritin steining. Such results suggest that the iron accumulation in this model as well as in PD may be a result of nigral degeneration, but unbalanced increase in iron with respect to the amount of ferritin may contribute to the progression of the disease by inducing oxidative stress.
引用
收藏
页码:381 / 385
页数:5
相关论文
共 50 条
  • [1] An immuno-histochemical study of ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys
    Goto, K
    Mochizuki, H
    Imai, H
    Akiyama, H
    Mizuno, Y
    BRAIN RESEARCH, 1996, 724 (01) : 125 - 128
  • [2] IRON ACCUMULATION IN THE SUBSTANTIA-NIGRA OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP)-INDUCED HEMIPARKINSONIAN MONKEYS
    MOCHIZUKI, H
    IMAI, H
    ENDO, K
    YOKOMIZO, K
    MURATA, Y
    HATTORI, N
    MIZUNO, Y
    NEUROSCIENCE LETTERS, 1994, 168 (1-2) : 251 - 253
  • [3] DUODENAL-ULCER INDUCED BY MPTP (1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE)
    SZABO, S
    BROWN, A
    PIHAN, G
    DALI, H
    NEUMEYER, JL
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1985, 180 (03): : 567 - 571
  • [4] PARGYLINE AND DEPRENYL PREVENT THE NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN MONKEYS
    COHEN, G
    PASIK, P
    COHEN, B
    LEIST, A
    MYTILINEOU, C
    YAHR, MD
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 106 (01) : 209 - 210
  • [5] Evidence of oligodendrogliosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism
    Annese, V.
    Barcia, C.
    Ros-Bernal, F.
    Gomez, A.
    Ros, C. M.
    De Pablos, V.
    Fernandez-Villalba, E.
    De Stefano, M. E.
    Herrero, M-T
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2013, 39 (02) : 132 - 143
  • [6] NEW AMPHIBIAN MODELS FOR THE STUDY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP)
    BARBEAU, A
    DALLAIRE, L
    BUU, NT
    VEILLEUX, F
    BOYER, H
    DELANNEY, LE
    IRWIN, I
    LANGSTON, EB
    LANGSTON, JW
    LIFE SCIENCES, 1985, 36 (11) : 1125 - 1134
  • [7] STUDIES ON THE MECHANISM OF ACTION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP)
    COHEN, G
    MYTILINEOU, C
    LIFE SCIENCES, 1985, 36 (03) : 237 - 242
  • [8] PLACENTAL TOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN MICE
    SCHMAHL, W
    USLER, B
    TOXICOLOGY, 1991, 67 (01) : 63 - 74
  • [9] ON THE MECHANISMS UNDERLYING 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) NEUROTOXICITY
    HARIK, SI
    IACOFANO, LA
    SAYRE, LM
    ARORA, PK
    BLUE, P
    SCHMIDLEY, JW
    NEUROLOGY, 1986, 36 (04) : 288 - 289
  • [10] MUTAGENICITY OF MPTP (1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE) AND ITS METABOLITES
    CASHMAN, JR
    TOXICOLOGY, 1987, 43 (02) : 173 - 182